These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 35186841)

  • 21. The Association of HIV Control and Immunosuppression With Risk of Non-AIDS-Defining Cancer Risk Among Patients on Antiretroviral Therapy.
    Dickey BL; Yanik EL; Thompson Z; Burkholder G; Kitahata MM; Moore RD; Jacobson J; Mathews WC; Christopoulos KA; Fleming J; Napravnik S; Achenbach C; Coghill AE
    J Acquir Immune Defic Syndr; 2024 Mar; 95(3):275-282. PubMed ID: 37977197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of persistent low-level viremia among HIV patients on antiretroviral therapy: A prospective cohort study.
    Ding H; Xu J; Liu J; Wang Q; Kang J; Li X; Zhang Z; Han X; Jiang Y; Geng W; Shang H
    HIV Med; 2022 Mar; 23 Suppl 1():64-71. PubMed ID: 35293103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is HIV-1 viraemia below 20 copies/mL in antiretroviral-treated patients associated with virologic outcome?
    den Oudsten M; van Kampen J; Rijnders B; van de Vijver D; van der Ende M
    Infect Dis (Lond); 2019 Apr; 51(4):259-267. PubMed ID: 30729841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virological failure and treatment switch after ART initiation among people living with HIV with and without routine viral load monitoring in Asia.
    Teeraananchai S; Law M; Boettiger D; Mata N; Gupte N; Chan YL; Pham TN; Chaiwarith R; Ly PS; Chan YJ; Kiertiburanakul S; Khusuwan S; Zhang F; Yunihastuti E; Kumarasamy N; Pujari S; Azwa I; Somia IKA; Tanuma J; Ditangco R; Choi JY; Ng OT; Do CD; Gani Y; Ross J; Jiamsakul A;
    J Int AIDS Soc; 2022 Aug; 25(8):e25989. PubMed ID: 36028921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.
    ; Zwahlen M; Harris R; May M; Hogg R; Costagliola D; de Wolf F; Gill J; Fätkenheuer G; Lewden C; Saag M; Staszewski S; d'Arminio Monforte A; Casabona J; Lampe F; Justice A; von Wyl V; Egger M
    Int J Epidemiol; 2009 Dec; 38(6):1624-33. PubMed ID: 19820106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of AIDS-defining events at initiation of antiretroviral therapy on long-term mortality of HIV/AIDS patients in Southwestern China: a retrospective cohort study.
    Huang Y; Zhou O; Zheng Z; Xu Y; Shao Y; Qin C; Qin F; Lai J; Liu H; Chen R; Ye L; Liang H; Qin X; Jiang J
    AIDS Res Ther; 2020 Jul; 17(1):44. PubMed ID: 32680536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4 criteria improves the sensitivity of a clinical algorithm developed to identify viral failure in HIV-positive patients on antiretroviral therapy.
    Evans DH; Fox MP; Maskew M; McNamara L; MacPhail P; Mathews C; Sanne I
    J Int AIDS Soc; 2014; 17(1):19139. PubMed ID: 25227265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes and factors associated with survival of patients with HIV/AIDS initiating antiretroviral treatment in Liangshan Prefecture, southwest of China: A retrospective cohort study from 2005 to 2013.
    Zhang G; Gong Y; Wang Q; Deng L; Zhang S; Liao Q; Yu G; Wang K; Wang J; Ye S; Liu Z
    Medicine (Baltimore); 2016 Jul; 95(27):e3969. PubMed ID: 27399071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal analysis of immune reconstitution and metabolic changes in women living with HIV: A real-world observational study.
    Wang X; Xiao J; Zhang L; Liu Y; Chen N; Deng M; Song C; Liu T; Zhang Y; Zhao H
    Chin Med J (Engl); 2023 Sep; 136(18):2168-2177. PubMed ID: 37580056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho.
    Amstutz A; Nsakala BL; Vanobberghen F; Muhairwe J; Glass TR; Namane T; Mpholo T; Battegay M; Klimkait T; Labhardt ND
    PLoS Med; 2020 Sep; 17(9):e1003325. PubMed ID: 32936795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART.
    Taiwo BO; Li X; Palella F; Jacobson LP; Margolick JB; Detels R; Rinaldo CR; Phair JP
    HIV Med; 2009 Nov; 10(10):657-60. PubMed ID: 19601997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Survival analysis of long-term HIV/AIDS cases aged 15 years and over under antiretroviral treatment in Henan Province from 2002 to 2020].
    Yang WJ; Li J; Ma YM; Liu Y; Xuan SL; Li N
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jul; 56(7):919-925. PubMed ID: 35899343
    [No Abstract]   [Full Text] [Related]  

  • 33. Effectiveness of integrase strand transfer inhibitors among treatment-experienced patients in a clinical setting.
    Davy-Mendez T; Napravnik S; Zakharova O; Wohl DA; Farel CE; Eron JJ
    AIDS; 2019 Jun; 33(7):1187-1195. PubMed ID: 30870198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with human immunodeficiency virus-1 low-level viremia and its impact on virological and immunological outcomes: A retrospective cohort study in Beijing, China.
    Bai R; Lv S; Hua W; Su B; Wang S; Shao Y; Li Z; Liu A; Sun L; Dai L
    HIV Med; 2022 Mar; 23 Suppl 1():72-83. PubMed ID: 35293102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency of Viremic Episodes in HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy: A Cohort Study.
    Myer L; Dunning L; Lesosky M; Hsiao NY; Phillips T; Petro G; Zerbe A; McIntyre JA; Abrams EJ
    Clin Infect Dis; 2017 Feb; 64(4):422-427. PubMed ID: 27927852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two-year outcome of first-line antiretroviral therapy among HIV-1 vertically-infected children in Hanoi, Vietnam.
    Pham HV; Ishizaki A; Nguyen LV; Phan CT; Phung TT; Takemoto K; Pham AN; Bi X; Khu DT; Ichimura H
    Int J STD AIDS; 2015 Oct; 26(11):821-30. PubMed ID: 25332224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent Low-level Viremia While on Antiretroviral Therapy Is an Independent Risk Factor for Virologic Failure.
    Joya C; Won SH; Schofield C; Lalani T; Maves RC; Kronmann K; Deiss R; Okulicz J; Agan BK; Ganesan A
    Clin Infect Dis; 2019 Nov; 69(12):2145-2152. PubMed ID: 30785191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.
    Boender TS; Hoenderboom BM; Sigaloff KC; Hamers RL; Wellington M; Shamu T; Siwale M; Labib Maksimos EE; Nankya I; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Ondoa P; Rinke de Wit TF
    Clin Infect Dis; 2015 Dec; 61(11):1749-58. PubMed ID: 26240203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of antiretroviral therapy initiation time and baseline CD4
    Yang Y; Li Y; Zhang X; Zhang W; Ma Y; Jia X; Gondwe T; Wang Y; Shi X
    Glob Health Action; 2021 Jan; 14(1):1963527. PubMed ID: 34592916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya.
    Brooks K; Diero L; DeLong A; Balamane M; Reitsma M; Kemboi E; Orido M; Emonyi W; Coetzer M; Hogan J; Kantor R
    J Int AIDS Soc; 2016; 19(1):20798. PubMed ID: 27231099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.